PRJNA375882: Comprehensive Mouse Transcriptomic BodyMap
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Erg
|
ENSMUSG00000040732.21 | Erg |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Erg | mm39_v1_chr16_-_95260104_95260243 | 0.73 | 3.1e-13 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr16_-_19801781 | 25.87 |
ENSMUST00000058839.10
|
Klhl6
|
kelch-like 6 |
chr10_-_81335966 | 24.30 |
ENSMUST00000053646.7
|
S1pr4
|
sphingosine-1-phosphate receptor 4 |
chr1_+_130793406 | 22.48 |
ENSMUST00000038829.7
|
Fcmr
|
Fc fragment of IgM receptor |
chr19_-_11243530 | 22.20 |
ENSMUST00000169159.3
|
Ms4a1
|
membrane-spanning 4-domains, subfamily A, member 1 |
chr7_+_24596806 | 18.70 |
ENSMUST00000003469.8
|
Cd79a
|
CD79A antigen (immunoglobulin-associated alpha) |
chr3_-_90603013 | 18.42 |
ENSMUST00000069960.12
ENSMUST00000117167.2 |
S100a9
|
S100 calcium binding protein A9 (calgranulin B) |
chr1_-_133617824 | 18.02 |
ENSMUST00000189524.2
ENSMUST00000169295.8 |
Lax1
|
lymphocyte transmembrane adaptor 1 |
chr7_-_125968653 | 17.33 |
ENSMUST00000205642.2
ENSMUST00000032997.8 ENSMUST00000206793.2 |
Lat
|
linker for activation of T cells |
chr16_+_36755338 | 16.75 |
ENSMUST00000023531.15
|
Hcls1
|
hematopoietic cell specific Lyn substrate 1 |
chr7_-_83304698 | 15.96 |
ENSMUST00000145610.8
|
Il16
|
interleukin 16 |
chr3_+_90511068 | 15.66 |
ENSMUST00000001046.7
|
S100a4
|
S100 calcium binding protein A4 |
chr10_+_5543769 | 15.62 |
ENSMUST00000051809.10
|
Myct1
|
myc target 1 |
chr9_+_21437440 | 15.51 |
ENSMUST00000086361.12
ENSMUST00000173769.3 |
AB124611
|
cDNA sequence AB124611 |
chr11_-_106278892 | 15.17 |
ENSMUST00000106813.9
ENSMUST00000141146.2 |
Icam2
|
intercellular adhesion molecule 2 |
chr15_-_66432938 | 15.14 |
ENSMUST00000048372.7
|
Tmem71
|
transmembrane protein 71 |
chr14_+_40853734 | 15.09 |
ENSMUST00000022314.10
ENSMUST00000170719.2 |
Sftpa1
|
surfactant associated protein A1 |
chr6_-_16898440 | 14.97 |
ENSMUST00000031533.11
|
Tfec
|
transcription factor EC |
chr14_+_44340111 | 14.96 |
ENSMUST00000074839.7
|
Ear2
|
eosinophil-associated, ribonuclease A family, member 2 |
chr4_-_129467430 | 14.41 |
ENSMUST00000102596.8
|
Lck
|
lymphocyte protein tyrosine kinase |
chrX_+_47235313 | 14.38 |
ENSMUST00000033427.7
|
Sash3
|
SAM and SH3 domain containing 3 |
chr2_-_148285450 | 14.33 |
ENSMUST00000099269.4
|
Cd93
|
CD93 antigen |
chr7_-_126817639 | 14.00 |
ENSMUST00000152267.8
ENSMUST00000106314.8 |
Septin1
|
septin 1 |
chr6_-_129449739 | 13.58 |
ENSMUST00000112076.9
ENSMUST00000184581.3 |
Clec7a
|
C-type lectin domain family 7, member a |
chr5_-_140986312 | 13.55 |
ENSMUST00000085786.7
|
Card11
|
caspase recruitment domain family, member 11 |
chr16_-_95260104 | 13.51 |
ENSMUST00000176345.10
ENSMUST00000121809.11 ENSMUST00000233664.2 ENSMUST00000122199.10 |
Erg
|
ETS transcription factor |
chr14_-_32907023 | 13.46 |
ENSMUST00000130509.10
ENSMUST00000061753.15 |
Wdfy4
|
WD repeat and FYVE domain containing 4 |
chr7_+_126895463 | 13.43 |
ENSMUST00000106306.9
ENSMUST00000120857.8 |
Itgal
|
integrin alpha L |
chr6_-_48685108 | 13.39 |
ENSMUST00000126422.3
ENSMUST00000119315.2 ENSMUST00000053661.7 |
Gimap6
|
GTPase, IMAP family member 6 |
chr17_+_28426752 | 13.03 |
ENSMUST00000002327.6
ENSMUST00000233560.2 ENSMUST00000233958.2 ENSMUST00000233170.2 |
Def6
|
differentially expressed in FDCP 6 |
chr1_+_40554513 | 12.86 |
ENSMUST00000027237.12
|
Il18rap
|
interleukin 18 receptor accessory protein |
chrX_-_9335525 | 12.76 |
ENSMUST00000015484.10
|
Cybb
|
cytochrome b-245, beta polypeptide |
chr14_+_51366512 | 12.75 |
ENSMUST00000095923.4
|
Rnase6
|
ribonuclease, RNase A family, 6 |
chr9_+_7445822 | 12.56 |
ENSMUST00000034497.8
|
Mmp3
|
matrix metallopeptidase 3 |
chr11_-_106606076 | 12.51 |
ENSMUST00000080853.11
ENSMUST00000183610.8 ENSMUST00000103069.10 ENSMUST00000106796.9 |
Pecam1
|
platelet/endothelial cell adhesion molecule 1 |
chr1_-_192883743 | 12.30 |
ENSMUST00000043550.11
|
Traf3ip3
|
TRAF3 interacting protein 3 |
chr14_-_44057096 | 12.16 |
ENSMUST00000100691.4
|
Ear1
|
eosinophil-associated, ribonuclease A family, member 1 |
chr3_+_84573499 | 12.00 |
ENSMUST00000107682.2
|
Tmem154
|
transmembrane protein 154 |
chr10_-_62343516 | 11.66 |
ENSMUST00000020271.13
|
Srgn
|
serglycin |
chr9_+_123902143 | 11.65 |
ENSMUST00000168841.3
ENSMUST00000055918.7 |
Ccr2
|
chemokine (C-C motif) receptor 2 |
chr7_-_126736979 | 11.50 |
ENSMUST00000049931.6
|
Spn
|
sialophorin |
chr1_-_192883642 | 11.47 |
ENSMUST00000192020.6
|
Traf3ip3
|
TRAF3 interacting protein 3 |
chr7_-_126817475 | 11.41 |
ENSMUST00000106313.8
ENSMUST00000142356.3 |
Septin1
|
septin 1 |
chr2_+_103800459 | 11.30 |
ENSMUST00000111143.8
ENSMUST00000138815.2 |
Lmo2
|
LIM domain only 2 |
chr10_+_127157784 | 11.12 |
ENSMUST00000219511.2
|
Arhgap9
|
Rho GTPase activating protein 9 |
chr6_+_48715971 | 11.04 |
ENSMUST00000054368.7
ENSMUST00000140054.3 ENSMUST00000204168.2 ENSMUST00000204408.2 |
Gimap1
Gm28053
|
GTPase, IMAP family member 1 predicted gene, 28053 |
chr10_+_127159609 | 11.02 |
ENSMUST00000069548.7
|
Arhgap9
|
Rho GTPase activating protein 9 |
chr17_+_48666919 | 10.85 |
ENSMUST00000224001.2
ENSMUST00000024792.8 ENSMUST00000225849.2 |
Treml1
|
triggering receptor expressed on myeloid cells-like 1 |
chr14_-_70761507 | 10.85 |
ENSMUST00000022692.5
|
Sftpc
|
surfactant associated protein C |
chr10_+_127159568 | 10.84 |
ENSMUST00000219026.2
|
Arhgap9
|
Rho GTPase activating protein 9 |
chr13_-_41640757 | 10.81 |
ENSMUST00000021794.14
|
Nedd9
|
neural precursor cell expressed, developmentally down-regulated gene 9 |
chr2_+_103800553 | 10.64 |
ENSMUST00000111140.3
ENSMUST00000111139.3 |
Lmo2
|
LIM domain only 2 |
chr3_-_95799242 | 10.64 |
ENSMUST00000171519.2
ENSMUST00000036360.13 ENSMUST00000090476.10 |
BC028528
|
cDNA sequence BC028528 |
chr2_+_29968596 | 10.61 |
ENSMUST00000045246.8
|
Pkn3
|
protein kinase N3 |
chr11_-_106605772 | 10.43 |
ENSMUST00000124958.3
|
Pecam1
|
platelet/endothelial cell adhesion molecule 1 |
chr16_+_57369595 | 10.38 |
ENSMUST00000159414.2
|
Filip1l
|
filamin A interacting protein 1-like |
chr6_+_60921456 | 10.33 |
ENSMUST00000129603.4
ENSMUST00000204333.2 |
Mmrn1
|
multimerin 1 |
chr11_+_61544085 | 10.25 |
ENSMUST00000004959.3
|
Grap
|
GRB2-related adaptor protein |
chr9_+_55997246 | 10.15 |
ENSMUST00000059206.8
|
Pstpip1
|
proline-serine-threonine phosphatase-interacting protein 1 |
chr1_+_170104889 | 10.10 |
ENSMUST00000179976.3
|
Sh2d1b1
|
SH2 domain containing 1B1 |
chr7_-_30741532 | 10.09 |
ENSMUST00000160689.8
ENSMUST00000202395.4 ENSMUST00000162733.8 ENSMUST00000162087.8 ENSMUST00000009831.14 |
Fxyd5
|
FXYD domain-containing ion transport regulator 5 |
chr2_+_32536594 | 10.01 |
ENSMUST00000113272.8
ENSMUST00000009705.14 ENSMUST00000167841.8 |
Eng
|
endoglin |
chr14_+_71011744 | 9.95 |
ENSMUST00000022698.8
|
Dok2
|
docking protein 2 |
chr1_-_131127825 | 9.92 |
ENSMUST00000068564.15
|
Rassf5
|
Ras association (RalGDS/AF-6) domain family member 5 |
chrX_-_7956682 | 9.72 |
ENSMUST00000033505.7
|
Was
|
Wiskott-Aldrich syndrome |
chr11_+_61376257 | 9.66 |
ENSMUST00000064783.10
ENSMUST00000040522.7 |
Mfap4
|
microfibrillar-associated protein 4 |
chr14_-_122153185 | 9.59 |
ENSMUST00000055475.9
|
Gpr18
|
G protein-coupled receptor 18 |
chr4_-_129452148 | 9.52 |
ENSMUST00000167288.8
ENSMUST00000134336.3 |
Lck
|
lymphocyte protein tyrosine kinase |
chr7_-_30741497 | 9.49 |
ENSMUST00000162116.8
ENSMUST00000159924.8 |
Fxyd5
|
FXYD domain-containing ion transport regulator 5 |
chr1_-_54965470 | 9.42 |
ENSMUST00000179030.8
ENSMUST00000044359.16 |
Ankrd44
|
ankyrin repeat domain 44 |
chr7_+_126895423 | 9.40 |
ENSMUST00000117762.8
|
Itgal
|
integrin alpha L |
chr10_-_75776437 | 9.38 |
ENSMUST00000219979.2
|
Gm867
|
predicted gene 867 |
chr8_-_89362745 | 9.32 |
ENSMUST00000034087.9
|
Snx20
|
sorting nexin 20 |
chr1_+_171216480 | 9.30 |
ENSMUST00000056449.9
|
Arhgap30
|
Rho GTPase activating protein 30 |
chr17_-_32622525 | 9.24 |
ENSMUST00000135618.8
ENSMUST00000063824.14 |
Rasal3
|
RAS protein activator like 3 |
chr13_-_37234213 | 9.23 |
ENSMUST00000164727.8
|
F13a1
|
coagulation factor XIII, A1 subunit |
chr16_-_45940602 | 9.22 |
ENSMUST00000023336.10
|
Cd96
|
CD96 antigen |
chr2_-_164198427 | 9.20 |
ENSMUST00000109367.10
|
Slpi
|
secretory leukocyte peptidase inhibitor |
chr11_-_52173391 | 9.19 |
ENSMUST00000086844.10
|
Tcf7
|
transcription factor 7, T cell specific |
chr4_-_129452180 | 9.14 |
ENSMUST00000067240.11
|
Lck
|
lymphocyte protein tyrosine kinase |
chr4_+_126042250 | 9.14 |
ENSMUST00000106150.3
|
Eva1b
|
eva-1 homolog B (C. elegans) |
chr14_-_44112974 | 9.08 |
ENSMUST00000179200.2
|
Ear1
|
eosinophil-associated, ribonuclease A family, member 1 |
chr9_-_44920899 | 9.08 |
ENSMUST00000102832.3
|
Cd3e
|
CD3 antigen, epsilon polypeptide |
chr9_-_88613967 | 8.99 |
ENSMUST00000098486.4
|
Bcl2a1d
|
B cell leukemia/lymphoma 2 related protein A1d |
chr2_+_164897547 | 8.96 |
ENSMUST00000017799.12
ENSMUST00000073707.9 |
Cd40
|
CD40 antigen |
chr18_-_35873493 | 8.92 |
ENSMUST00000235495.2
ENSMUST00000237919.2 ENSMUST00000237405.2 |
Sting1
|
stimulator of interferon response cGAMP interactor 1 |
chr3_+_137046828 | 8.84 |
ENSMUST00000122064.8
ENSMUST00000119475.6 |
Emcn
|
endomucin |
chr11_+_49554430 | 8.81 |
ENSMUST00000043873.10
ENSMUST00000076006.5 |
Scgb3a1
|
secretoglobin, family 3A, member 1 |
chr7_-_30119227 | 8.78 |
ENSMUST00000208740.2
ENSMUST00000075062.5 |
Hcst
|
hematopoietic cell signal transducer |
chr2_+_164897583 | 8.77 |
ENSMUST00000081310.11
ENSMUST00000140951.8 |
Cd40
|
CD40 antigen |
chr7_-_30741762 | 8.67 |
ENSMUST00000161684.8
|
Fxyd5
|
FXYD domain-containing ion transport regulator 5 |
chr7_-_30741237 | 8.62 |
ENSMUST00000161805.8
|
Fxyd5
|
FXYD domain-containing ion transport regulator 5 |
chr19_-_4240984 | 8.62 |
ENSMUST00000045864.4
|
Tbc1d10c
|
TBC1 domain family, member 10c |
chr3_-_10273628 | 8.55 |
ENSMUST00000029041.6
|
Fabp4
|
fatty acid binding protein 4, adipocyte |
chr1_+_135060431 | 8.48 |
ENSMUST00000187985.7
ENSMUST00000049449.11 |
Ptpn7
|
protein tyrosine phosphatase, non-receptor type 7 |
chr3_-_130524024 | 8.48 |
ENSMUST00000079085.11
|
Rpl34
|
ribosomal protein L34 |
chr6_-_136918495 | 8.37 |
ENSMUST00000111892.8
|
Arhgdib
|
Rho, GDP dissociation inhibitor (GDI) beta |
chr9_+_89081262 | 8.35 |
ENSMUST00000068569.5
|
Bcl2a1b
|
B cell leukemia/lymphoma 2 related protein A1b |
chr7_-_30741512 | 8.32 |
ENSMUST00000159753.2
|
Fxyd5
|
FXYD domain-containing ion transport regulator 5 |
chr19_-_4241034 | 8.25 |
ENSMUST00000237495.2
|
Tbc1d10c
|
TBC1 domain family, member 10c |
chr16_+_44586085 | 8.14 |
ENSMUST00000057488.15
|
Cd200r1
|
CD200 receptor 1 |
chr7_+_126895531 | 8.11 |
ENSMUST00000170971.8
|
Itgal
|
integrin alpha L |
chr7_-_44180700 | 8.07 |
ENSMUST00000205506.2
|
Spib
|
Spi-B transcription factor (Spi-1/PU.1 related) |
chr17_+_43700327 | 8.06 |
ENSMUST00000113599.2
ENSMUST00000224278.2 ENSMUST00000225466.2 |
Adgrf5
|
adhesion G protein-coupled receptor F5 |
chr16_+_17615146 | 8.06 |
ENSMUST00000012161.5
ENSMUST00000232577.2 |
Scarf2
|
scavenger receptor class F, member 2 |
chr3_-_20296337 | 8.00 |
ENSMUST00000001921.3
|
Cpa3
|
carboxypeptidase A3, mast cell |
chr3_+_137046935 | 8.00 |
ENSMUST00000197511.2
|
Emcn
|
endomucin |
chr1_-_80643024 | 8.00 |
ENSMUST00000187774.7
|
Dock10
|
dedicator of cytokinesis 10 |
chr12_-_58315949 | 7.97 |
ENSMUST00000062254.4
|
Clec14a
|
C-type lectin domain family 14, member a |
chr17_-_32622497 | 7.91 |
ENSMUST00000137458.2
|
Rasal3
|
RAS protein activator like 3 |
chr4_-_63321591 | 7.84 |
ENSMUST00000035724.5
|
Akna
|
AT-hook transcription factor |
chr6_+_87755046 | 7.84 |
ENSMUST00000032133.5
|
Gp9
|
glycoprotein 9 (platelet) |
chr8_+_70261323 | 7.81 |
ENSMUST00000036074.15
ENSMUST00000123453.2 |
Gmip
|
Gem-interacting protein |
chr1_-_80642969 | 7.74 |
ENSMUST00000190983.7
ENSMUST00000191449.2 |
Dock10
|
dedicator of cytokinesis 10 |
chr1_-_170755136 | 7.69 |
ENSMUST00000046322.14
ENSMUST00000159171.2 |
Fcrla
|
Fc receptor-like A |
chr12_+_98234884 | 7.67 |
ENSMUST00000075072.6
|
Gpr65
|
G-protein coupled receptor 65 |
chr8_+_93687561 | 7.58 |
ENSMUST00000072939.8
|
Slc6a2
|
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
chr17_+_43671314 | 7.56 |
ENSMUST00000226087.2
|
Adgrf5
|
adhesion G protein-coupled receptor F5 |
chr19_+_6451667 | 7.56 |
ENSMUST00000113471.3
ENSMUST00000113469.3 |
Rasgrp2
|
RAS, guanyl releasing protein 2 |
chr17_+_75742881 | 7.55 |
ENSMUST00000164192.9
|
Rasgrp3
|
RAS, guanyl releasing protein 3 |
chr1_+_152683627 | 7.52 |
ENSMUST00000027754.7
|
Ncf2
|
neutrophil cytosolic factor 2 |
chr17_-_18104182 | 7.43 |
ENSMUST00000061516.8
|
Fpr1
|
formyl peptide receptor 1 |
chr19_-_5518515 | 7.40 |
ENSMUST00000236256.2
ENSMUST00000025844.6 |
Ctsw
|
cathepsin W |
chr8_+_89015705 | 7.39 |
ENSMUST00000171456.9
|
Adcy7
|
adenylate cyclase 7 |
chr7_+_101043568 | 7.39 |
ENSMUST00000098243.4
|
Arap1
|
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1 |
chr9_+_88838953 | 7.38 |
ENSMUST00000098485.4
|
Bcl2a1a
|
B cell leukemia/lymphoma 2 related protein A1a |
chrX_+_106299484 | 7.38 |
ENSMUST00000101294.9
ENSMUST00000118820.8 ENSMUST00000120971.8 |
Gpr174
|
G protein-coupled receptor 174 |
chr18_-_35873554 | 7.35 |
ENSMUST00000115728.5
|
Sting1
|
stimulator of interferon response cGAMP interactor 1 |
chr11_-_72441054 | 7.34 |
ENSMUST00000021154.7
|
Spns3
|
spinster homolog 3 |
chr10_-_18887701 | 7.33 |
ENSMUST00000105527.2
|
Tnfaip3
|
tumor necrosis factor, alpha-induced protein 3 |
chr7_+_28488380 | 7.30 |
ENSMUST00000209035.2
ENSMUST00000059857.8 |
Rinl
|
Ras and Rab interactor-like |
chr10_+_61133549 | 7.27 |
ENSMUST00000219375.2
|
Prf1
|
perforin 1 (pore forming protein) |
chr3_-_130523954 | 7.21 |
ENSMUST00000196202.5
ENSMUST00000133802.6 ENSMUST00000062601.14 ENSMUST00000200517.2 |
Rpl34
|
ribosomal protein L34 |
chr13_+_55517545 | 7.13 |
ENSMUST00000063771.14
|
Rgs14
|
regulator of G-protein signaling 14 |
chr5_-_113788451 | 7.13 |
ENSMUST00000047936.13
|
Cmklr1
|
chemokine-like receptor 1 |
chr10_+_28544356 | 7.09 |
ENSMUST00000060409.13
ENSMUST00000056097.11 ENSMUST00000105516.9 |
Themis
|
thymocyte selection associated |
chr6_+_4003904 | 7.09 |
ENSMUST00000031670.10
|
Gng11
|
guanine nucleotide binding protein (G protein), gamma 11 |
chr1_-_106641940 | 6.92 |
ENSMUST00000112751.2
|
Bcl2
|
B cell leukemia/lymphoma 2 |
chr8_-_71964379 | 6.91 |
ENSMUST00000048452.6
|
Plvap
|
plasmalemma vesicle associated protein |
chr3_+_87754310 | 6.89 |
ENSMUST00000029709.7
|
Sh2d2a
|
SH2 domain containing 2A |
chr7_+_141040988 | 6.88 |
ENSMUST00000053670.12
|
Cracr2b
|
calcium release activated channel regulator 2B |
chr10_+_58207229 | 6.86 |
ENSMUST00000238939.2
|
Lims1
|
LIM and senescent cell antigen-like domains 1 |
chr15_-_9529898 | 6.85 |
ENSMUST00000228782.2
ENSMUST00000003981.6 |
Il7r
|
interleukin 7 receptor |
chr1_+_135060994 | 6.84 |
ENSMUST00000167080.3
|
Ptpn7
|
protein tyrosine phosphatase, non-receptor type 7 |
chr3_+_87754057 | 6.81 |
ENSMUST00000107581.9
|
Sh2d2a
|
SH2 domain containing 2A |
chr18_-_35873257 | 6.78 |
ENSMUST00000235302.2
|
Sting1
|
stimulator of interferon response cGAMP interactor 1 |
chr4_-_118346952 | 6.77 |
ENSMUST00000184261.8
|
Tie1
|
tyrosine kinase with immunoglobulin-like and EGF-like domains 1 |
chr6_+_21986445 | 6.75 |
ENSMUST00000115382.8
|
Cped1
|
cadherin-like and PC-esterase domain containing 1 |
chr11_-_79421397 | 6.66 |
ENSMUST00000103236.4
ENSMUST00000170799.8 ENSMUST00000170422.4 |
Evi2a
Evi2
|
ecotropic viral integration site 2a ecotropic viral integration site 2 |
chr13_-_55677109 | 6.66 |
ENSMUST00000223563.2
|
Dok3
|
docking protein 3 |
chrX_+_158623460 | 6.65 |
ENSMUST00000112451.8
ENSMUST00000112453.9 |
Sh3kbp1
|
SH3-domain kinase binding protein 1 |
chr2_+_118428690 | 6.65 |
ENSMUST00000038341.8
|
Bub1b
|
BUB1B, mitotic checkpoint serine/threonine kinase |
chr7_+_43086432 | 6.64 |
ENSMUST00000070518.4
|
Nkg7
|
natural killer cell group 7 sequence |
chr17_-_52133594 | 6.62 |
ENSMUST00000129667.8
ENSMUST00000169480.8 ENSMUST00000148559.2 |
Satb1
|
special AT-rich sequence binding protein 1 |
chr13_+_102830029 | 6.60 |
ENSMUST00000022124.10
ENSMUST00000171267.2 ENSMUST00000167144.2 ENSMUST00000170878.2 |
Cd180
|
CD180 antigen |
chr9_+_123901979 | 6.53 |
ENSMUST00000171719.8
|
Ccr2
|
chemokine (C-C motif) receptor 2 |
chr4_-_127207773 | 6.51 |
ENSMUST00000053753.8
|
Gja4
|
gap junction protein, alpha 4 |
chr11_-_103235475 | 6.48 |
ENSMUST00000041385.14
|
Arhgap27
|
Rho GTPase activating protein 27 |
chr11_-_103254257 | 6.48 |
ENSMUST00000092557.6
|
Arhgap27
|
Rho GTPase activating protein 27 |
chr1_-_156301821 | 6.44 |
ENSMUST00000188027.2
ENSMUST00000187507.7 ENSMUST00000189661.7 |
Soat1
|
sterol O-acyltransferase 1 |
chr9_+_110709353 | 6.44 |
ENSMUST00000155014.2
|
Als2cl
|
ALS2 C-terminal like |
chr1_+_159871943 | 6.43 |
ENSMUST00000163892.8
|
4930523C07Rik
|
RIKEN cDNA 4930523C07 gene |
chr11_-_46203047 | 6.38 |
ENSMUST00000129474.2
ENSMUST00000093166.11 ENSMUST00000165599.9 |
Cyfip2
|
cytoplasmic FMR1 interacting protein 2 |
chr2_+_84670956 | 6.38 |
ENSMUST00000111625.2
|
Slc43a1
|
solute carrier family 43, member 1 |
chr6_-_136918671 | 6.36 |
ENSMUST00000032344.12
|
Arhgdib
|
Rho, GDP dissociation inhibitor (GDI) beta |
chr14_+_52091156 | 6.35 |
ENSMUST00000169070.2
ENSMUST00000074477.7 |
Ear6
|
eosinophil-associated, ribonuclease A family, member 6 |
chr9_+_99333474 | 6.29 |
ENSMUST00000163199.5
|
Nme9
|
NME/NM23 family member 9 |
chr1_+_152683568 | 6.25 |
ENSMUST00000190323.7
|
Ncf2
|
neutrophil cytosolic factor 2 |
chr18_-_14815807 | 6.24 |
ENSMUST00000040964.13
ENSMUST00000234524.2 ENSMUST00000092041.11 ENSMUST00000040924.9 |
Ss18
|
SS18, nBAF chromatin remodeling complex subunit |
chr17_+_33743144 | 6.22 |
ENSMUST00000087623.13
ENSMUST00000234715.2 ENSMUST00000234497.2 |
Adamts10
|
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 10 |
chr2_-_31973795 | 6.22 |
ENSMUST00000056406.7
|
Fam78a
|
family with sequence similarity 78, member A |
chr2_+_84670543 | 6.21 |
ENSMUST00000111624.8
|
Slc43a1
|
solute carrier family 43, member 1 |
chr16_+_95058417 | 6.15 |
ENSMUST00000113861.8
ENSMUST00000113854.8 ENSMUST00000113862.8 ENSMUST00000037154.14 ENSMUST00000113855.8 |
Kcnj15
|
potassium inwardly-rectifying channel, subfamily J, member 15 |
chr8_+_104828253 | 6.14 |
ENSMUST00000034339.10
|
Cdh5
|
cadherin 5 |
chr2_-_73284262 | 6.13 |
ENSMUST00000102679.8
|
Wipf1
|
WAS/WASL interacting protein family, member 1 |
chrX_+_158086253 | 6.12 |
ENSMUST00000112491.2
|
Rps6ka3
|
ribosomal protein S6 kinase polypeptide 3 |
chr7_-_143294051 | 6.07 |
ENSMUST00000119499.8
|
Osbpl5
|
oxysterol binding protein-like 5 |
chr14_+_51366306 | 6.06 |
ENSMUST00000226210.2
|
Rnase6
|
ribonuclease, RNase A family, 6 |
chr9_-_66826928 | 6.06 |
ENSMUST00000041139.9
|
Rab8b
|
RAB8B, member RAS oncogene family |
chr2_+_26473870 | 5.98 |
ENSMUST00000100290.13
ENSMUST00000238983.2 ENSMUST00000102907.13 |
Egfl7
|
EGF-like domain 7 |
chr3_+_103767581 | 5.97 |
ENSMUST00000029433.9
|
Ptpn22
|
protein tyrosine phosphatase, non-receptor type 22 (lymphoid) |
chr2_+_164790139 | 5.92 |
ENSMUST00000017881.3
|
Mmp9
|
matrix metallopeptidase 9 |
chr7_-_132415257 | 5.92 |
ENSMUST00000097999.9
|
Fam53b
|
family with sequence similarity 53, member B |
chr7_+_98138904 | 5.91 |
ENSMUST00000205956.2
|
Lrrc32
|
leucine rich repeat containing 32 |
chr3_+_88523440 | 5.87 |
ENSMUST00000177498.8
ENSMUST00000176500.8 |
Arhgef2
|
rho/rac guanine nucleotide exchange factor (GEF) 2 |
chr6_-_123266820 | 5.87 |
ENSMUST00000032239.11
ENSMUST00000177367.8 |
Clec4e
|
C-type lectin domain family 4, member e |
chr3_-_14843512 | 5.74 |
ENSMUST00000094365.11
|
Car1
|
carbonic anhydrase 1 |
chr6_+_129374441 | 5.71 |
ENSMUST00000112081.9
ENSMUST00000112079.3 |
Clec1b
|
C-type lectin domain family 1, member b |
chrX_+_163156359 | 5.69 |
ENSMUST00000033751.8
|
Vegfd
|
vascular endothelial growth factor D |
chr11_+_89921121 | 5.68 |
ENSMUST00000092788.4
|
Tmem100
|
transmembrane protein 100 |
chr2_+_33106062 | 5.67 |
ENSMUST00000004208.7
|
Angptl2
|
angiopoietin-like 2 |
chr4_-_118347249 | 5.65 |
ENSMUST00000047421.6
|
Tie1
|
tyrosine kinase with immunoglobulin-like and EGF-like domains 1 |
chr7_+_43086554 | 5.64 |
ENSMUST00000206741.2
|
Nkg7
|
natural killer cell group 7 sequence |
chr17_+_47908025 | 5.63 |
ENSMUST00000183206.2
|
Ccnd3
|
cyclin D3 |
chr2_-_92876398 | 5.59 |
ENSMUST00000111272.3
ENSMUST00000178666.8 ENSMUST00000147339.3 |
Prdm11
|
PR domain containing 11 |
chr4_-_43558386 | 5.57 |
ENSMUST00000130353.2
|
Tln1
|
talin 1 |
chr16_+_10297923 | 5.56 |
ENSMUST00000230395.2
|
Ciita
|
class II transactivator |
chrX_+_152506577 | 5.55 |
ENSMUST00000140575.8
ENSMUST00000208373.2 ENSMUST00000185492.7 ENSMUST00000149514.8 |
Nbdy
|
negative regulator of P-body association |
chr6_-_131224305 | 5.55 |
ENSMUST00000032306.15
ENSMUST00000088867.7 |
Klra2
|
killer cell lectin-like receptor, subfamily A, member 2 |
chr19_+_41017714 | 5.50 |
ENSMUST00000051806.12
ENSMUST00000112200.3 |
Dntt
|
deoxynucleotidyltransferase, terminal |
chr9_-_20888054 | 5.50 |
ENSMUST00000054197.7
|
S1pr2
|
sphingosine-1-phosphate receptor 2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.6 | 22.9 | GO:0090673 | endothelial cell-matrix adhesion(GO:0090673) |
6.1 | 18.4 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
6.1 | 18.2 | GO:0090265 | immune complex clearance by monocytes and macrophages(GO:0002436) regulation of immune complex clearance by monocytes and macrophages(GO:0090264) positive regulation of immune complex clearance by monocytes and macrophages(GO:0090265) negative regulation of eosinophil activation(GO:1902567) positive regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000451) |
4.1 | 16.6 | GO:0033374 | protein localization to secretory granule(GO:0033366) protein localization to mast cell secretory granule(GO:0033367) protease localization to mast cell secretory granule(GO:0033368) maintenance of protein location in mast cell secretory granule(GO:0033370) T cell secretory granule organization(GO:0033371) maintenance of protease location in mast cell secretory granule(GO:0033373) protein localization to T cell secretory granule(GO:0033374) protease localization to T cell secretory granule(GO:0033375) maintenance of protein location in T cell secretory granule(GO:0033377) maintenance of protease location in T cell secretory granule(GO:0033379) granzyme B localization to T cell secretory granule(GO:0033380) maintenance of granzyme B location in T cell secretory granule(GO:0033382) |
3.8 | 11.5 | GO:0001807 | regulation of type IV hypersensitivity(GO:0001807) |
3.4 | 30.9 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
3.4 | 10.1 | GO:2000566 | positive regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000566) |
3.3 | 10.0 | GO:0003032 | detection of oxygen(GO:0003032) cardiac jelly development(GO:1905072) |
3.2 | 9.7 | GO:0002625 | regulation of T cell antigen processing and presentation(GO:0002625) |
3.2 | 9.6 | GO:0002304 | gamma-delta intraepithelial T cell differentiation(GO:0002304) CD8-positive, gamma-delta intraepithelial T cell differentiation(GO:0002305) |
3.1 | 9.4 | GO:2000439 | positive regulation of monocyte extravasation(GO:2000439) |
3.1 | 12.2 | GO:2000349 | negative regulation of CD40 signaling pathway(GO:2000349) |
2.9 | 11.6 | GO:0060807 | cardiogenic plate morphogenesis(GO:0003142) regulation of transcription from RNA polymerase II promoter involved in definitive endodermal cell fate specification(GO:0060807) |
2.6 | 2.6 | GO:0038190 | neuropilin signaling pathway(GO:0038189) VEGF-activated neuropilin signaling pathway(GO:0038190) |
2.5 | 33.1 | GO:0070474 | positive regulation of uterine smooth muscle contraction(GO:0070474) |
2.5 | 10.1 | GO:0002767 | immune response-inhibiting signal transduction(GO:0002765) immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
2.4 | 9.7 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
2.3 | 6.9 | GO:0032685 | negative regulation of granulocyte macrophage colony-stimulating factor production(GO:0032685) |
2.3 | 13.8 | GO:0051142 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
2.1 | 6.4 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
2.1 | 12.7 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
2.0 | 14.1 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
2.0 | 5.9 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
1.9 | 16.9 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
1.8 | 5.3 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
1.8 | 5.3 | GO:0038091 | VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
1.7 | 10.5 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
1.7 | 13.6 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
1.7 | 10.0 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
1.7 | 26.4 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
1.6 | 14.7 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
1.6 | 4.9 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
1.6 | 12.8 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
1.5 | 4.6 | GO:0021759 | globus pallidus development(GO:0021759) |
1.5 | 9.1 | GO:0006742 | NADP catabolic process(GO:0006742) |
1.5 | 4.5 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
1.5 | 4.5 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
1.5 | 23.7 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
1.4 | 4.3 | GO:1904093 | regulation of autophagic cell death(GO:1904092) negative regulation of autophagic cell death(GO:1904093) |
1.4 | 9.8 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
1.4 | 19.4 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
1.4 | 6.9 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
1.4 | 4.1 | GO:0002545 | chronic inflammatory response to non-antigenic stimulus(GO:0002545) regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002880) |
1.4 | 15.1 | GO:0008228 | opsonization(GO:0008228) |
1.4 | 21.9 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
1.4 | 4.1 | GO:1904828 | regulation of hydrogen sulfide biosynthetic process(GO:1904826) positive regulation of hydrogen sulfide biosynthetic process(GO:1904828) |
1.3 | 4.0 | GO:1903904 | negative regulation of establishment of T cell polarity(GO:1903904) negative regulation of T cell migration(GO:2000405) |
1.3 | 5.4 | GO:0045659 | negative regulation of neutrophil differentiation(GO:0045659) |
1.3 | 6.7 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
1.3 | 6.6 | GO:0038032 | termination of G-protein coupled receptor signaling pathway(GO:0038032) |
1.3 | 3.9 | GO:0071640 | regulation of macrophage inflammatory protein 1 alpha production(GO:0071640) |
1.3 | 5.2 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
1.3 | 10.2 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
1.3 | 2.5 | GO:0060585 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
1.3 | 12.6 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
1.3 | 5.0 | GO:0080120 | CAAX-box protein processing(GO:0071586) CAAX-box protein maturation(GO:0080120) |
1.2 | 7.4 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
1.2 | 17.3 | GO:0006968 | cellular defense response(GO:0006968) |
1.2 | 15.7 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
1.2 | 27.8 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
1.2 | 9.6 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
1.2 | 15.6 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) positive regulation of phospholipid biosynthetic process(GO:0071073) |
1.1 | 6.9 | GO:0034436 | glycoprotein transport(GO:0034436) |
1.1 | 6.8 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
1.1 | 11.3 | GO:0045346 | regulation of MHC class II biosynthetic process(GO:0045346) |
1.1 | 2.2 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) positive regulation of dendritic cell apoptotic process(GO:2000670) |
1.1 | 3.3 | GO:0010710 | regulation of collagen catabolic process(GO:0010710) |
1.1 | 7.6 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
1.1 | 22.5 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
1.1 | 3.2 | GO:1903699 | tarsal gland development(GO:1903699) |
1.1 | 4.2 | GO:0000390 | spliceosomal complex disassembly(GO:0000390) |
1.0 | 16.0 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
1.0 | 4.8 | GO:0031296 | B cell costimulation(GO:0031296) |
0.9 | 3.8 | GO:0016240 | autophagosome docking(GO:0016240) zymogen granule exocytosis(GO:0070625) positive regulation of pancreatic juice secretion(GO:0090187) |
0.9 | 3.8 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.9 | 4.7 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.9 | 9.2 | GO:0002681 | somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) embryonic genitalia morphogenesis(GO:0030538) T cell receptor V(D)J recombination(GO:0033153) |
0.9 | 3.6 | GO:0017126 | nucleologenesis(GO:0017126) |
0.9 | 5.3 | GO:0040010 | positive regulation of growth rate(GO:0040010) |
0.9 | 28.0 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.9 | 2.6 | GO:0051892 | negative regulation of cardioblast differentiation(GO:0051892) |
0.9 | 5.2 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.9 | 29.0 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.9 | 4.3 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
0.8 | 5.9 | GO:0097340 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) |
0.8 | 15.0 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.8 | 3.3 | GO:0086053 | AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
0.8 | 18.0 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.8 | 9.7 | GO:0048251 | UV protection(GO:0009650) elastic fiber assembly(GO:0048251) |
0.8 | 26.5 | GO:0002467 | germinal center formation(GO:0002467) |
0.8 | 4.8 | GO:0032627 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) |
0.8 | 8.5 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.8 | 9.2 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.8 | 2.3 | GO:0061010 | gall bladder development(GO:0061010) |
0.8 | 11.5 | GO:0051709 | regulation of killing of cells of other organism(GO:0051709) |
0.8 | 6.1 | GO:0015919 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.7 | 2.2 | GO:0016340 | calcium-dependent cell-matrix adhesion(GO:0016340) |
0.7 | 2.9 | GO:2000230 | negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
0.7 | 2.9 | GO:0014022 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.7 | 2.2 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
0.7 | 2.9 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
0.7 | 3.6 | GO:1901355 | response to rapamycin(GO:1901355) |
0.7 | 1.4 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.7 | 5.7 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.7 | 6.4 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.7 | 10.5 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.7 | 4.2 | GO:0002528 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
0.7 | 2.1 | GO:0006713 | glucocorticoid catabolic process(GO:0006713) |
0.7 | 8.9 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.7 | 2.7 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
0.7 | 12.1 | GO:0043383 | negative T cell selection(GO:0043383) |
0.7 | 2.6 | GO:0090309 | C-5 methylation of cytosine(GO:0090116) positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.7 | 3.3 | GO:1903677 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.6 | 8.9 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.6 | 3.2 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.6 | 8.2 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
0.6 | 4.4 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.6 | 5.0 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.6 | 6.9 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.6 | 1.9 | GO:2000847 | negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.6 | 6.9 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.6 | 3.7 | GO:1990481 | mRNA pseudouridine synthesis(GO:1990481) |
0.6 | 2.5 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.6 | 4.9 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.6 | 1.8 | GO:0071477 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
0.6 | 4.8 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.6 | 8.9 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.6 | 3.0 | GO:0002159 | desmosome assembly(GO:0002159) |
0.6 | 8.7 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.6 | 2.3 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) |
0.6 | 2.8 | GO:1904976 | response to bleomycin(GO:1904975) cellular response to bleomycin(GO:1904976) |
0.6 | 3.4 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
0.5 | 2.7 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.5 | 7.1 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.5 | 3.0 | GO:1990166 | protein localization to site of double-strand break(GO:1990166) |
0.5 | 8.9 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
0.5 | 4.0 | GO:0006868 | glutamine transport(GO:0006868) |
0.5 | 3.4 | GO:2000138 | positive regulation of skeletal muscle tissue growth(GO:0048633) positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
0.5 | 2.9 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
0.5 | 1.4 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.5 | 3.2 | GO:0007527 | adult somatic muscle development(GO:0007527) |
0.4 | 41.6 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.4 | 1.7 | GO:0032672 | regulation of type I hypersensitivity(GO:0001810) positive regulation of type I hypersensitivity(GO:0001812) type I hypersensitivity(GO:0016068) interleukin-3 production(GO:0032632) regulation of interleukin-3 production(GO:0032672) positive regulation of interleukin-3 production(GO:0032752) interleukin-3 biosynthetic process(GO:0042223) regulation of interleukin-3 biosynthetic process(GO:0045399) positive regulation of interleukin-3 biosynthetic process(GO:0045401) positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045425) |
0.4 | 2.6 | GO:0050916 | sensory perception of sweet taste(GO:0050916) sensory perception of umami taste(GO:0050917) |
0.4 | 4.2 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.4 | 1.7 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.4 | 4.1 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.4 | 8.8 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.4 | 5.1 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.4 | 3.7 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.4 | 7.0 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.4 | 3.6 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.4 | 1.1 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.4 | 1.1 | GO:0098501 | polynucleotide dephosphorylation(GO:0098501) |
0.3 | 6.6 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.3 | 6.6 | GO:0036037 | CD8-positive, alpha-beta T cell activation(GO:0036037) CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.3 | 15.7 | GO:0045026 | plasma membrane fusion(GO:0045026) |
0.3 | 6.5 | GO:0015874 | norepinephrine transport(GO:0015874) |
0.3 | 2.0 | GO:1903351 | response to dopamine(GO:1903350) cellular response to dopamine(GO:1903351) |
0.3 | 1.3 | GO:0071544 | diphosphoinositol polyphosphate catabolic process(GO:0071544) |
0.3 | 2.0 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.3 | 1.0 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
0.3 | 2.0 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.3 | 1.0 | GO:0044727 | DNA demethylation of male pronucleus(GO:0044727) |
0.3 | 3.1 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.3 | 3.7 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.3 | 10.2 | GO:0001945 | lymph vessel development(GO:0001945) |
0.3 | 0.6 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.3 | 8.6 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.3 | 2.1 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.3 | 1.8 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.3 | 24.3 | GO:0007189 | adenylate cyclase-activating G-protein coupled receptor signaling pathway(GO:0007189) |
0.3 | 2.4 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.3 | 1.8 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.3 | 12.6 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.3 | 1.1 | GO:2000434 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
0.3 | 2.0 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.3 | 4.7 | GO:0016322 | neuron remodeling(GO:0016322) |
0.3 | 7.7 | GO:0010447 | response to acidic pH(GO:0010447) |
0.3 | 12.7 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.3 | 33.7 | GO:0030183 | B cell differentiation(GO:0030183) |
0.3 | 0.8 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.3 | 3.7 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.3 | 2.1 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
0.3 | 6.2 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
0.3 | 9.6 | GO:0035411 | catenin import into nucleus(GO:0035411) |
0.3 | 8.0 | GO:0002042 | cell migration involved in sprouting angiogenesis(GO:0002042) |
0.3 | 1.0 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.3 | 7.4 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.3 | 5.8 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.3 | 3.8 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.3 | 3.3 | GO:0002507 | tolerance induction(GO:0002507) |
0.2 | 1.2 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.2 | 1.5 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.2 | 6.7 | GO:0030220 | platelet formation(GO:0030220) |
0.2 | 0.7 | GO:0046038 | GMP catabolic process(GO:0046038) |
0.2 | 4.6 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.2 | 1.0 | GO:0071348 | cellular response to interleukin-11(GO:0071348) |
0.2 | 0.7 | GO:0032827 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.2 | 25.4 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.2 | 0.9 | GO:0009257 | histidine biosynthetic process(GO:0000105) 10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
0.2 | 0.9 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.2 | 0.7 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.2 | 0.7 | GO:0039663 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.2 | 14.5 | GO:0034605 | cellular response to heat(GO:0034605) |
0.2 | 0.6 | GO:0021553 | olfactory nerve development(GO:0021553) |
0.2 | 1.5 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.2 | 3.5 | GO:0042730 | fibrinolysis(GO:0042730) |
0.2 | 1.2 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.2 | 2.7 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.2 | 1.6 | GO:0044857 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) caveola assembly(GO:0070836) |
0.2 | 3.6 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.2 | 5.5 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
0.2 | 2.2 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.2 | 4.0 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
0.2 | 1.8 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.2 | 3.5 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.2 | 1.7 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.2 | 5.5 | GO:0033198 | response to ATP(GO:0033198) |
0.2 | 28.4 | GO:0007596 | blood coagulation(GO:0007596) |
0.2 | 6.9 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.2 | 1.6 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.2 | 6.5 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.2 | 4.9 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
0.2 | 3.3 | GO:0042554 | superoxide anion generation(GO:0042554) |
0.2 | 6.0 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
0.2 | 2.0 | GO:0046697 | decidualization(GO:0046697) |
0.2 | 3.5 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.2 | 2.7 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.2 | 0.5 | GO:0006238 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) pyrimidine ribonucleotide salvage(GO:0010138) pyrimidine nucleotide salvage(GO:0032262) UMP salvage(GO:0044206) CMP metabolic process(GO:0046035) |
0.2 | 3.6 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.2 | 0.8 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
0.2 | 1.1 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.2 | 4.1 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.1 | 2.5 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.1 | 24.0 | GO:0042113 | B cell activation(GO:0042113) |
0.1 | 0.9 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.1 | 0.7 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.1 | 5.4 | GO:0050913 | sensory perception of bitter taste(GO:0050913) |
0.1 | 1.2 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.1 | 2.6 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.1 | 0.5 | GO:1990839 | response to endothelin(GO:1990839) |
0.1 | 3.2 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.1 | 0.5 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.1 | 1.0 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.1 | 5.4 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 0.4 | GO:0032053 | ciliary basal body organization(GO:0032053) |
0.1 | 7.6 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.1 | 23.1 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.1 | 0.5 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.1 | 1.1 | GO:1901673 | regulation of mitotic spindle assembly(GO:1901673) |
0.1 | 1.1 | GO:0097369 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.1 | 5.7 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.1 | 4.0 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.1 | 5.1 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.1 | 1.6 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.1 | 0.6 | GO:0071236 | cellular response to antibiotic(GO:0071236) |
0.1 | 4.7 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.1 | 2.1 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.1 | 15.1 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.1 | 0.4 | GO:0036228 | protein targeting to nuclear inner membrane(GO:0036228) |
0.1 | 6.3 | GO:0014068 | positive regulation of phosphatidylinositol 3-kinase signaling(GO:0014068) |
0.1 | 0.1 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.1 | 1.7 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.1 | 0.8 | GO:0015809 | arginine transport(GO:0015809) |
0.1 | 0.5 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.1 | 6.1 | GO:0015914 | phospholipid transport(GO:0015914) |
0.1 | 1.0 | GO:0051256 | mitotic spindle midzone assembly(GO:0051256) |
0.1 | 17.6 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.1 | 1.2 | GO:0080009 | mRNA methylation(GO:0080009) |
0.1 | 5.1 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.1 | 0.4 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.1 | 0.3 | GO:0060268 | negative regulation of respiratory burst(GO:0060268) |
0.1 | 10.7 | GO:0010631 | epithelial cell migration(GO:0010631) |
0.1 | 2.0 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 4.4 | GO:0007032 | endosome organization(GO:0007032) |
0.1 | 3.3 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.1 | 4.3 | GO:0051567 | histone H3-K9 methylation(GO:0051567) |
0.1 | 2.0 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.1 | 0.3 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
0.1 | 1.6 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.1 | 9.2 | GO:0000910 | cytokinesis(GO:0000910) |
0.1 | 0.5 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.1 | 0.1 | GO:1904925 | positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
0.1 | 2.4 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.5 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.1 | 6.7 | GO:0031398 | positive regulation of protein ubiquitination(GO:0031398) |
0.1 | 2.1 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.1 | 2.1 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
0.1 | 0.4 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.1 | 0.4 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.1 | 0.2 | GO:0051715 | cytolysis in other organism(GO:0051715) |
0.1 | 2.2 | GO:0035904 | aorta development(GO:0035904) |
0.1 | 0.3 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.0 | 1.8 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.0 | 2.2 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
0.0 | 1.6 | GO:0006360 | transcription from RNA polymerase I promoter(GO:0006360) |
0.0 | 3.0 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.0 | 4.5 | GO:0006641 | triglyceride metabolic process(GO:0006641) |
0.0 | 2.8 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.0 | 1.5 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.0 | 2.7 | GO:0006497 | protein lipidation(GO:0006497) |
0.0 | 0.8 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.0 | 2.2 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
0.0 | 1.1 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.0 | 1.2 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
0.0 | 15.9 | GO:0007264 | small GTPase mediated signal transduction(GO:0007264) |
0.0 | 5.7 | GO:0043547 | positive regulation of GTPase activity(GO:0043547) |
0.0 | 0.2 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
0.0 | 0.9 | GO:0030325 | adrenal gland development(GO:0030325) |
0.0 | 0.5 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.0 | 1.3 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
0.0 | 0.4 | GO:0043507 | positive regulation of JUN kinase activity(GO:0043507) |
0.0 | 1.9 | GO:0006805 | xenobiotic metabolic process(GO:0006805) |
0.0 | 2.0 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.0 | 0.2 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.0 | 0.7 | GO:0007099 | centriole replication(GO:0007099) |
0.0 | 0.4 | GO:0045953 | negative regulation of natural killer cell mediated cytotoxicity(GO:0045953) |
0.0 | 6.2 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.0 | 0.3 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.0 | 0.2 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.0 | 0.5 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.0 | 0.1 | GO:0048016 | inositol phosphate-mediated signaling(GO:0048016) |
0.0 | 0.1 | GO:0044154 | histone H3-K14 acetylation(GO:0044154) |
0.0 | 0.1 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.0 | 1.3 | GO:0021549 | cerebellum development(GO:0021549) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.2 | 30.9 | GO:0034687 | integrin alphaL-beta2 complex(GO:0034687) |
2.5 | 22.9 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
2.5 | 7.6 | GO:0034665 | integrin alpha1-beta1 complex(GO:0034665) |
2.3 | 22.9 | GO:0019815 | B cell receptor complex(GO:0019815) |
1.9 | 9.7 | GO:0071953 | elastic fiber(GO:0071953) |
1.9 | 9.6 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
1.9 | 29.8 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
1.7 | 5.2 | GO:0005607 | laminin-2 complex(GO:0005607) |
1.7 | 29.4 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
1.7 | 10.1 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
1.5 | 16.6 | GO:0042629 | mast cell granule(GO:0042629) |
1.5 | 7.3 | GO:0044194 | cytolytic granule(GO:0044194) |
1.4 | 7.0 | GO:0030690 | Noc1p-Noc2p complex(GO:0030690) |
1.4 | 40.4 | GO:0042101 | T cell receptor complex(GO:0042101) |
1.3 | 5.4 | GO:0031680 | G-protein beta/gamma-subunit complex(GO:0031680) |
1.2 | 35.8 | GO:0000242 | pericentriolar material(GO:0000242) |
1.1 | 3.4 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
1.0 | 4.0 | GO:0060171 | stereocilium membrane(GO:0060171) |
1.0 | 5.0 | GO:0045160 | myosin I complex(GO:0045160) |
1.0 | 16.8 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.9 | 3.5 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.8 | 8.5 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.7 | 4.5 | GO:0042583 | chromaffin granule(GO:0042583) |
0.7 | 3.7 | GO:0000799 | nuclear condensin complex(GO:0000799) |
0.7 | 10.2 | GO:0016589 | NURF complex(GO:0016589) |
0.7 | 15.6 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.7 | 2.8 | GO:1990696 | stereocilia ankle link complex(GO:0002142) USH2 complex(GO:1990696) |
0.7 | 4.1 | GO:0005683 | U7 snRNP(GO:0005683) |
0.6 | 4.5 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.6 | 3.0 | GO:0005914 | spot adherens junction(GO:0005914) |
0.6 | 20.0 | GO:0031527 | filopodium membrane(GO:0031527) |
0.6 | 2.3 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.5 | 27.2 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.5 | 12.6 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.5 | 3.4 | GO:0097443 | sorting endosome(GO:0097443) |
0.5 | 6.7 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.5 | 4.1 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.4 | 27.9 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.4 | 0.4 | GO:1990589 | ATF4-CREB1 transcription factor complex(GO:1990589) |
0.4 | 9.8 | GO:0005922 | connexon complex(GO:0005922) |
0.4 | 2.5 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.4 | 15.1 | GO:0005771 | multivesicular body(GO:0005771) |
0.3 | 2.1 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.3 | 5.1 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.3 | 0.9 | GO:0032156 | septin cytoskeleton(GO:0032156) |
0.3 | 1.5 | GO:1990130 | Iml1 complex(GO:1990130) |
0.3 | 4.4 | GO:0005915 | zonula adherens(GO:0005915) |
0.3 | 7.4 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.3 | 0.8 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.3 | 4.7 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.3 | 16.9 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.3 | 1.6 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.3 | 1.9 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.3 | 4.8 | GO:0036038 | MKS complex(GO:0036038) |
0.3 | 1.9 | GO:0036396 | MIS complex(GO:0036396) |
0.2 | 6.2 | GO:0071564 | npBAF complex(GO:0071564) |
0.2 | 0.7 | GO:1902560 | GMP reductase complex(GO:1902560) |
0.2 | 9.0 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.2 | 4.3 | GO:0001891 | phagocytic cup(GO:0001891) |
0.2 | 2.1 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.2 | 130.4 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.2 | 3.5 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
0.2 | 2.1 | GO:0061574 | ASAP complex(GO:0061574) |
0.2 | 16.9 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.2 | 14.0 | GO:0000791 | euchromatin(GO:0000791) |
0.2 | 5.2 | GO:0005605 | basal lamina(GO:0005605) |
0.2 | 43.1 | GO:0005884 | actin filament(GO:0005884) |
0.2 | 3.0 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.2 | 2.2 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.2 | 2.6 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.2 | 17.1 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.2 | 0.5 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
0.2 | 6.6 | GO:0097440 | apical dendrite(GO:0097440) |
0.2 | 42.7 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.2 | 1.8 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.2 | 8.2 | GO:0031901 | early endosome membrane(GO:0031901) |
0.2 | 13.1 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.2 | 28.8 | GO:0001726 | ruffle(GO:0001726) |
0.1 | 3.7 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.1 | 2.6 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.1 | 2.8 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 75.2 | GO:0031012 | extracellular matrix(GO:0031012) |
0.1 | 1.0 | GO:0001940 | male pronucleus(GO:0001940) |
0.1 | 16.8 | GO:0016605 | PML body(GO:0016605) |
0.1 | 0.5 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.1 | 1.7 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 28.8 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.1 | 2.6 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 0.7 | GO:0098536 | deuterosome(GO:0098536) |
0.1 | 16.2 | GO:0000922 | spindle pole(GO:0000922) |
0.1 | 1.6 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.1 | 1.0 | GO:0030897 | HOPS complex(GO:0030897) |
0.1 | 0.5 | GO:0034448 | EGO complex(GO:0034448) |
0.1 | 2.9 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.9 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.1 | 1.5 | GO:0031011 | Ino80 complex(GO:0031011) |
0.1 | 3.6 | GO:0032040 | small-subunit processome(GO:0032040) |
0.1 | 3.0 | GO:0035861 | site of double-strand break(GO:0035861) |
0.1 | 17.4 | GO:0005911 | cell-cell junction(GO:0005911) |
0.1 | 0.4 | GO:0000322 | storage vacuole(GO:0000322) |
0.1 | 2.7 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 5.5 | GO:0016459 | myosin complex(GO:0016459) |
0.1 | 1.7 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.1 | 0.5 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.1 | 43.4 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 0.1 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 8.4 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.1 | 0.4 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.1 | 0.7 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 21.8 | GO:0005925 | focal adhesion(GO:0005925) |
0.1 | 6.9 | GO:0005912 | adherens junction(GO:0005912) |
0.1 | 0.4 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.1 | 0.4 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.1 | 6.4 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 21.3 | GO:0009986 | cell surface(GO:0009986) |
0.1 | 5.1 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.0 | 0.5 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.0 | 0.2 | GO:0005642 | annulate lamellae(GO:0005642) |
0.0 | 5.9 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.0 | 3.0 | GO:0005814 | centriole(GO:0005814) |
0.0 | 43.9 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 1.3 | GO:0045171 | intercellular bridge(GO:0045171) |
0.0 | 5.7 | GO:0031965 | nuclear membrane(GO:0031965) |
0.0 | 0.5 | GO:0030686 | 90S preribosome(GO:0030686) |
0.0 | 0.4 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.0 | 0.2 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.0 | 15.6 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.6 | 33.1 | GO:0042610 | CD8 receptor binding(GO:0042610) |
6.2 | 30.9 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
6.1 | 18.2 | GO:0035717 | chemokine (C-C motif) ligand 7 binding(GO:0035717) |
4.2 | 41.5 | GO:0050786 | RAGE receptor binding(GO:0050786) |
2.5 | 7.6 | GO:0005333 | norepinephrine transmembrane transporter activity(GO:0005333) |
2.3 | 6.9 | GO:0034189 | very-low-density lipoprotein particle binding(GO:0034189) |
2.1 | 29.8 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
1.9 | 30.6 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
1.9 | 13.3 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
1.8 | 14.3 | GO:0001849 | complement component C1q binding(GO:0001849) |
1.8 | 5.3 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
1.8 | 16.0 | GO:0042609 | CD4 receptor binding(GO:0042609) |
1.7 | 7.0 | GO:0097199 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097199) |
1.6 | 14.7 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
1.3 | 7.6 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
1.3 | 33.0 | GO:0051400 | BH domain binding(GO:0051400) |
1.3 | 10.0 | GO:0005534 | galactose binding(GO:0005534) |
1.2 | 13.6 | GO:0050700 | CARD domain binding(GO:0050700) |
1.2 | 7.3 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
1.2 | 6.1 | GO:0030911 | TPR domain binding(GO:0030911) |
1.1 | 15.2 | GO:0030274 | LIM domain binding(GO:0030274) |
1.0 | 4.1 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
1.0 | 4.1 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
1.0 | 4.1 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
1.0 | 5.0 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
1.0 | 12.9 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
1.0 | 3.8 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.9 | 4.7 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.9 | 3.7 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.9 | 7.3 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.9 | 22.2 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.8 | 5.9 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
0.8 | 5.8 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.8 | 3.3 | GO:0086077 | gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling(GO:0086077) |
0.8 | 7.4 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
0.8 | 7.3 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.8 | 8.0 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.8 | 2.3 | GO:0052596 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
0.8 | 4.5 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.7 | 9.6 | GO:0052813 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.7 | 2.2 | GO:0004821 | histidine-tRNA ligase activity(GO:0004821) |
0.7 | 2.1 | GO:0008281 | sulfonylurea receptor activity(GO:0008281) |
0.7 | 2.1 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.7 | 5.4 | GO:0051425 | PTB domain binding(GO:0051425) |
0.7 | 10.0 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.7 | 36.5 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.6 | 2.5 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.6 | 10.0 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.6 | 1.8 | GO:0004958 | prostaglandin F receptor activity(GO:0004958) |
0.6 | 2.3 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.6 | 5.7 | GO:0004064 | arylesterase activity(GO:0004064) |
0.6 | 5.2 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.6 | 2.3 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
0.6 | 4.0 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
0.6 | 1.7 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.5 | 45.2 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.5 | 7.4 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.5 | 4.7 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.5 | 9.3 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.5 | 2.0 | GO:0004921 | interleukin-11 receptor activity(GO:0004921) interleukin-11 binding(GO:0019970) |
0.5 | 36.0 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.5 | 5.4 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.5 | 28.5 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.5 | 64.4 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.5 | 1.8 | GO:0035827 | rubidium ion transmembrane transporter activity(GO:0035827) |
0.4 | 13.4 | GO:0043274 | phospholipase binding(GO:0043274) |
0.4 | 6.7 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.4 | 2.2 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.4 | 1.7 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.4 | 7.1 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.4 | 10.8 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.4 | 14.1 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.4 | 2.4 | GO:0048495 | Roundabout binding(GO:0048495) |
0.4 | 13.9 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.4 | 11.3 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.4 | 8.5 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.4 | 18.0 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.4 | 2.1 | GO:0019961 | interferon binding(GO:0019961) |
0.3 | 2.0 | GO:0004359 | glutaminase activity(GO:0004359) |
0.3 | 10.0 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.3 | 24.4 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.3 | 37.6 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.3 | 2.2 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.3 | 7.3 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.3 | 19.5 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.3 | 64.8 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.3 | 2.8 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.3 | 4.9 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.3 | 3.0 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.3 | 10.0 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.3 | 2.6 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.3 | 4.6 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.3 | 14.0 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.3 | 10.2 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.3 | 6.0 | GO:0017166 | vinculin binding(GO:0017166) |
0.3 | 3.8 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.3 | 1.1 | GO:0046403 | polynucleotide 3'-phosphatase activity(GO:0046403) |
0.3 | 8.0 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.2 | 0.7 | GO:0016657 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
0.2 | 91.5 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.2 | 2.9 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.2 | 3.6 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.2 | 0.7 | GO:0004572 | mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity(GO:0004572) |
0.2 | 0.9 | GO:0004329 | formate-tetrahydrofolate ligase activity(GO:0004329) |
0.2 | 2.6 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.2 | 5.0 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.2 | 20.1 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.2 | 4.1 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.2 | 2.9 | GO:1901567 | icosanoid binding(GO:0050542) arachidonic acid binding(GO:0050544) fatty acid derivative binding(GO:1901567) |
0.2 | 3.7 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.2 | 9.5 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.2 | 1.2 | GO:0032450 | maltose alpha-glucosidase activity(GO:0032450) |
0.2 | 1.3 | GO:0000298 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) |
0.2 | 23.6 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.2 | 0.5 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.2 | 2.9 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.2 | 0.7 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
0.2 | 1.4 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.2 | 20.8 | GO:0005178 | integrin binding(GO:0005178) |
0.2 | 2.1 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.2 | 0.8 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.2 | 11.7 | GO:0005518 | collagen binding(GO:0005518) |
0.2 | 0.7 | GO:0033906 | hyaluronoglucuronidase activity(GO:0033906) |
0.2 | 2.3 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.2 | 5.6 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.2 | 12.4 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.2 | 1.4 | GO:0031432 | titin binding(GO:0031432) |
0.2 | 10.2 | GO:1990782 | protein tyrosine kinase binding(GO:1990782) |
0.2 | 3.8 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.2 | 8.5 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.2 | 0.9 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.2 | 4.2 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 1.5 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 4.5 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 4.0 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.1 | 5.4 | GO:0005504 | fatty acid binding(GO:0005504) |
0.1 | 8.6 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.1 | 2.9 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 12.6 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.1 | 6.1 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.1 | 1.8 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.1 | 1.9 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.1 | 1.1 | GO:1990948 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
0.1 | 4.3 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.1 | 1.1 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.1 | 0.7 | GO:0016019 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.1 | 1.1 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.1 | 17.9 | GO:0019903 | protein phosphatase binding(GO:0019903) |
0.1 | 3.4 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.1 | 8.1 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.1 | 6.1 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.1 | 1.0 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 1.0 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 0.3 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
0.1 | 1.5 | GO:0001164 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.1 | 0.8 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) |
0.1 | 7.1 | GO:0002039 | p53 binding(GO:0002039) |
0.1 | 0.4 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.1 | 16.8 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 1.9 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.1 | 1.6 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.1 | 1.2 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 6.7 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.1 | 3.2 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.1 | 11.6 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.1 | 3.4 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 7.4 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.1 | 0.5 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.1 | 0.5 | GO:0043515 | kinetochore binding(GO:0043515) |
0.1 | 0.4 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.1 | 0.3 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 0.8 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.1 | 2.1 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 0.8 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 0.5 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.1 | 0.5 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.1 | 1.4 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.1 | 7.4 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.1 | 1.6 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 0.8 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.1 | 1.9 | GO:0019843 | rRNA binding(GO:0019843) |
0.1 | 3.6 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.1 | 1.1 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 1.0 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.1 | 2.2 | GO:0017022 | myosin binding(GO:0017022) |
0.1 | 0.4 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.1 | 2.5 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.1 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
0.0 | 3.7 | GO:0035064 | methylated histone binding(GO:0035064) |
0.0 | 1.2 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 2.5 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 0.9 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.6 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.0 | 0.1 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
0.0 | 0.2 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
0.0 | 1.1 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.0 | 9.9 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.0 | 6.8 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
0.0 | 1.9 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 2.8 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.0 | 0.5 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.0 | 0.3 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 0.6 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 0.2 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.0 | 0.2 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.0 | 0.5 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.0 | 0.5 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.1 | GO:0046030 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) inositol trisphosphate phosphatase activity(GO:0046030) |
0.0 | 0.1 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 0.6 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
0.0 | 7.3 | GO:0005525 | GTP binding(GO:0005525) |
0.0 | 1.5 | GO:0030507 | spectrin binding(GO:0030507) |
0.0 | 0.4 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 2.1 | GO:0004386 | helicase activity(GO:0004386) |
0.0 | 1.8 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 1.0 | GO:0004519 | endonuclease activity(GO:0004519) |
0.0 | 1.2 | GO:0008565 | protein transporter activity(GO:0008565) |
0.0 | 0.2 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.0 | 0.3 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.0 | 0.3 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 49.6 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
1.2 | 12.3 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
1.2 | 84.8 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
1.1 | 24.7 | PID S1P S1P4 PATHWAY | S1P4 pathway |
1.1 | 15.3 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
1.1 | 17.3 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
1.0 | 51.7 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
1.0 | 27.8 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.9 | 100.6 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.9 | 5.4 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.8 | 65.9 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.8 | 32.0 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.8 | 27.9 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.8 | 11.5 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.7 | 28.3 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.7 | 8.9 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.7 | 4.4 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.7 | 27.1 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.7 | 8.6 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.6 | 8.3 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.6 | 19.6 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.6 | 12.9 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.6 | 23.7 | PID BCR 5PATHWAY | BCR signaling pathway |
0.6 | 32.6 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.6 | 7.0 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.5 | 7.0 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.5 | 25.9 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.5 | 20.9 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.4 | 9.4 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.4 | 11.9 | PID ALK1 PATHWAY | ALK1 signaling events |
0.4 | 2.2 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.4 | 5.3 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.3 | 7.4 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.3 | 15.2 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.3 | 9.7 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.3 | 7.0 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.3 | 13.7 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.3 | 10.0 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.3 | 55.6 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.3 | 14.6 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.3 | 2.9 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.2 | 8.1 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.2 | 3.2 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.2 | 4.8 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.2 | 20.3 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.2 | 8.5 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.2 | 2.9 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 7.8 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 14.0 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.1 | 2.1 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 14.6 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 7.1 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 2.7 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 1.6 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.1 | 5.9 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.1 | 2.8 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 1.1 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 2.2 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 2.1 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 2.9 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 0.9 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 2.6 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.1 | 4.6 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 6.6 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.1 | 2.7 | PID AURORA B PATHWAY | Aurora B signaling |
0.1 | 21.9 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 2.7 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 1.6 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 3.1 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.4 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 5.8 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 2.5 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.5 | 49.4 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
2.0 | 18.2 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
1.7 | 98.1 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
1.2 | 12.3 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
1.0 | 11.3 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
1.0 | 3.0 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
1.0 | 22.9 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.9 | 24.4 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.9 | 21.0 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.9 | 24.0 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.8 | 12.7 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.8 | 41.9 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.8 | 10.0 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.8 | 7.5 | REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | Genes involved in Signaling by the B Cell Receptor (BCR) |
0.8 | 4.5 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.7 | 8.3 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.7 | 9.2 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.6 | 11.5 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.6 | 18.5 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.6 | 7.0 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.6 | 10.7 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.5 | 1.0 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.5 | 7.8 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.5 | 2.3 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.4 | 27.8 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.4 | 25.0 | REACTOME G PROTEIN BETA GAMMA SIGNALLING | Genes involved in G-protein beta:gamma signalling |
0.4 | 7.4 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.4 | 9.8 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.4 | 14.0 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.4 | 14.0 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.4 | 9.4 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.4 | 8.5 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.3 | 7.6 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.3 | 3.6 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.3 | 10.9 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.3 | 4.1 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.3 | 37.8 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.3 | 26.3 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.3 | 8.6 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.3 | 15.8 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.3 | 6.1 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.3 | 62.1 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.3 | 25.5 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.3 | 3.6 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.2 | 4.3 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.2 | 45.7 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.2 | 9.6 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.2 | 4.2 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.2 | 2.1 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.2 | 10.9 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.2 | 2.7 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.2 | 4.7 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.2 | 6.1 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF RAS | Genes involved in CREB phosphorylation through the activation of Ras |
0.1 | 1.8 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 11.0 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.1 | 2.3 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.1 | 1.8 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.1 | 2.5 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 1.7 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 2.4 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.1 | 1.8 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 6.3 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.1 | 6.0 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.1 | 2.8 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 1.8 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 9.8 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.1 | 0.7 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 2.2 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 1.0 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.1 | 2.0 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.1 | 1.6 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.1 | 2.1 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.1 | 4.6 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 1.0 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 0.4 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.0 | 1.7 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.0 | 6.3 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.0 | 0.8 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 0.9 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 0.6 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.0 | 0.5 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 2.7 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.0 | 0.3 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.0 | 0.7 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.0 | 0.4 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.0 | 0.5 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.0 | 0.9 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |